What is the Amplia Therapeutics (ASX: ATX) share price?
The ATX share price is $0.115, down 4.17% for the day, based on the latest available ASX market data.
What is Amplia Therapeutics's market capitalisation?
Amplia Therapeutics has a market capitalisation of $59.0M, making it the 968th-largest security listed on the ASX.
Does Amplia Therapeutics pay a dividend?
ATX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is Amplia Therapeutics profitable?
In its most recent reported period (ending 31 Mar 2026), ATX reported revenue of $0 and a net loss of $3.5M.
How many ATX shares are on issue?
Amplia Therapeutics has approximately 513,312,000 shares on issue, based on its market capitalisation of $59.0M and current share price.
What sector is Amplia Therapeutics in?
Amplia Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.
When did Amplia Therapeutics list on the ASX?
Amplia Therapeutics listed on the Australian Securities Exchange on 12 Jan 2014.
